Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the company, will be interacting with Analyst/Institutional Investors on September 26, 2022 via in person meeting. The copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. The above date is subject to change and change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.
The above information is a part of company’s filings submitted to BSE.
